OTTAWA — The Canadian Paediatric Surveillance Program (CPSP) is releasing new data about the use of cannabis for medical purposes and the incidence of Lyme disease, Zika-associated viruses and eating disorders in children and youth.
2017 data from surveillance studies and one-time surveys show:
The CPSP is a network of 2,700 Canadian paediatricians and paediatric subspecialists. It is a partnership between the Public Health Agency of Canada and the Canadian Paediatric Society. Through disease surveillance, the program generates valuable new knowledge to inform clinical research, practice and policy related to important rare conditions and evolving child health threats. Along with knowledge translation tools, including monthly tips on adverse drug reactions, the CPSP provides timely information to researchers, doctors, and health policy makers on both emerging and persisting health conditions affecting children and youth.
“Lack of information on rare diseases or severe complications is challenging for children and their families,” said Jonathon Maguire, CPSP Chair. “Being able to offer knowledge gained through our surveillance helps families to better understand these conditions and provides evidence for doctors on appropriate evaluation and treatment.”
To access the CPSP 2017 Results, click here.
The Canadian Paediatric Society is a national advocacy association that promotes the health needs of children and youth. Founded in 1922, the CPS represents more than 3,300 paediatricians, paediatric subspecialists and other child health professionals across Canada.
Last updated: Jul 12, 2018